- Home
- ACRV vs PRTS Comparison
ACRV vs PRTS Comparison
Compare ACRV & PRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- PRTS
- Stock Information
- Founded
- ACRV 2018
- PRTS 1995
- Country
- ACRV United States
- PRTS United States
- Employees
- ACRV N/A
- PRTS N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- PRTS Auto & Home Supply Stores
- Sector
- ACRV Health Care
- PRTS Consumer Discretionary
- Exchange
- ACRV Nasdaq
- PRTS Nasdaq
- Market Cap
- ACRV 47.8M
- PRTS 40.0M
- IPO Year
- ACRV 2022
- PRTS 2007
- Fundamental
- Price
- ACRV $2.01
- PRTS $0.72
- Analyst Decision
- ACRV Buy
- PRTS Hold
- Analyst Count
- ACRV 6
- PRTS 1
- Target Price
- ACRV $17.75
- PRTS $0.70
- AVG Volume (30 Days)
- ACRV 556.9K
- PRTS 1.1M
- Earning Date
- ACRV 11-12-2025
- PRTS 10-28-2025
- Dividend Yield
- ACRV N/A
- PRTS N/A
- EPS Growth
- ACRV N/A
- PRTS N/A
- EPS
- ACRV N/A
- PRTS N/A
- Revenue
- ACRV N/A
- PRTS $577,614,000.00
- Revenue This Year
- ACRV N/A
- PRTS N/A
- Revenue Next Year
- ACRV $805.34
- PRTS $2.62
- P/E Ratio
- ACRV N/A
- PRTS N/A
- Revenue Growth
- ACRV N/A
- PRTS N/A
- 52 Week Low
- ACRV $1.05
- PRTS $0.68
- 52 Week High
- ACRV $8.74
- PRTS $1.42
- Technical
- Relative Strength Index (RSI)
- ACRV 69.57
- PRTS 43.95
- Support Level
- ACRV $1.82
- PRTS $0.68
- Resistance Level
- ACRV $2.00
- PRTS $0.71
- Average True Range (ATR)
- ACRV 0.12
- PRTS 0.04
- MACD
- ACRV 0.01
- PRTS -0.00
- Stochastic Oscillator
- ACRV 87.68
- PRTS 33.17
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.